Biogen Inc. (BIIB)
NASDAQ: BIIB · IEX Real-Time Price · USD
228.82
-2.95 (-1.27%)
At close: Jul 2, 2024, 4:00 PM
230.50
+1.68 (0.73%)
After-hours: Jul 2, 2024, 5:45 PM EDT
Biogen Revenue
Biogen had revenue of $9.66B in the twelve months ending March 31, 2024, down -4.37% year-over-year. Revenue in the quarter ending March 31, 2024 was $2.29B, a -7.00% decrease year-over-year. In the year 2023, Biogen had annual revenue of $9.84B, a decrease of -3.32%.
Revenue (ttm)
$9.66B
Revenue Growth
-4.37%
P/S Ratio
3.45
Revenue / Employee
$1,276,499
Employees
7,570
Market Cap
33.32B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 9.84B | -337.80M | -3.32% |
Dec 31, 2022 | 10.17B | -808.30M | -7.36% |
Dec 31, 2021 | 10.98B | -2.46B | -18.32% |
Dec 31, 2020 | 13.44B | -933.30M | -6.49% |
Dec 31, 2019 | 14.38B | 925.00M | 6.88% |
Dec 31, 2018 | 13.45B | 1.18B | 9.61% |
Dec 31, 2017 | 12.27B | 825.10M | 7.21% |
Dec 31, 2016 | 11.45B | 685.00M | 6.36% |
Dec 31, 2015 | 10.76B | 1.06B | 10.93% |
Dec 31, 2014 | 9.70B | 2.77B | 39.97% |
Dec 31, 2013 | 6.93B | 1.42B | 25.66% |
Dec 31, 2012 | 5.52B | 467.83M | 9.27% |
Dec 31, 2011 | 5.05B | 332.21M | 7.04% |
Dec 31, 2010 | 4.72B | 339.08M | 7.75% |
Dec 31, 2009 | 4.38B | 279.84M | 6.83% |
Dec 31, 2008 | 4.10B | 925.89M | 29.19% |
Dec 31, 2007 | 3.17B | 488.57M | 18.21% |
Dec 31, 2006 | 2.68B | 260.55M | 10.76% |
Dec 31, 2005 | 2.42B | 210.94M | 9.54% |
Dec 31, 2004 | 2.21B | 1.53B | 225.62% |
Dec 31, 2003 | 679.18M | 274.96M | 68.02% |
Dec 31, 2002 | 404.22M | 131.55M | 48.24% |
Dec 31, 2001 | 272.68M | 118.00M | 76.28% |
Dec 31, 2000 | 154.68M | 36.68M | 31.08% |
Dec 31, 1999 | 118.00M | 31.04M | 35.70% |
Dec 31, 1998 | 86.96M | 42.35M | 94.95% |
Dec 31, 1997 | 44.61M | 14.60M | 48.64% |
Dec 31, 1996 | 30.01M | 6.37M | 26.96% |
Dec 31, 1995 | 23.64M | 16.19M | 217.56% |
Dec 31, 1994 | 7.44M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Centene | 155.52B |
GE HealthCare Technologies | 19.50B |
IQVIA Holdings | 15.07B |
Haleon | 14.31B |
ICON PLC | 8.23B |
Agilent Technologies | 6.59B |
ResMed | 4.58B |
Mettler-Toledo International | 3.79B |
BIIB News
- 54 minutes ago - Lost Money on Biogen Inc.(BIIB)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky - Accesswire
- 1 hour ago - Biogen Inc. Class Action: Levi & Korsinsky Reminds Biogen Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 22, 2024 – BIIB - Accesswire
- 1 hour ago - BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit - PRNewsWire
- 7 hours ago - Biogen Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information - BIIB - Accesswire
- 7 hours ago - Investors who lost money on Biogen Inc.(BIIB) should contact Levi & Korsinsky about pending Class Action - BIIB - Accesswire
- 7 hours ago - The Schall Law Firm Encourages Biogen Inc Investors Who Have Sustained Losses To Make Contact Be Mindful Of The Deadline In This Situation - Accesswire
- 7 hours ago - Lost Money on Biogen Inc. (BIIB)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky - Accesswire
- 7 hours ago - Biogen Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before July 22, 2024 to Discuss Your Rights - BIIB - Accesswire